Mechanisms and Evolution of Assembly-Line Polyketide Synthases
装配线聚酮化合物合成酶的机制和演变
基本信息
- 批准号:10394371
- 负责人:
- 金额:$ 40.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Acyl Carrier ProteinAnabolismAntibioticsBiologicalBiological AssayCandidate Disease GeneChemicalsClustered Regularly Interspaced Short Palindromic RepeatsComplexCryoelectron MicroscopyEngineeringEnzymatic BiochemistryEnzymesEpitopesEvolutionExperimental ModelsGene ConversionGenesGeneticGenetic ModelsGoalsHuman Cell LineIn VitroIndividualInvestigationKnock-outLaboratoriesLogicMolecular ConformationMonoclonal AntibodiesNamesNatural ProductsNocardiaNocardia InfectionsNucleotidesOrphanPhenotypePlayReactionResearchRoentgen RaysRoleSpecificityStreptomycesStructureTestingbaseflexibilitygenetic elementgenome-wideinsightknock-downmacrophagenovelpolyketide synthasereconstitutionsmall hairpin RNAvector
项目摘要
PROJECT DESCRIPTION
Assembly-line polyketide synthases (PKSs) are enzyme machines that catalyze vectorial biosynthesis of a
growing polyketide chain through a uniquely defined sequence of acyl carrier protein and ketosynthase
domains involving alternating chain translocation and elongation reactions. Notwithstanding the discovery of
>3000 naturally occurring assembly-line PKSs, we do not understand how they blend catalytic specificity with
evolutionary flexibility. Our lab is motivated by the goal of understanding the enzymology and evolution of
assembly-line PKSs while enhancing our ability to engineer known PKSs and decode “orphan” ones.
Our Goals for the next five years are to:
1) Understand the chemical logic of vectorial biosynthesis by an assembly-line PKS: We will study: (i) the
structural dynamics of individual PKS modules; (ii) how different conformations of a module enable its
elementary reactions; and (iii) the extent to which transitions between successive reactions are coordinated
across an assembly line. Our proposed mechanistic investigations will exploit: (i) our ability to functionally
reconstitute PKSs in vitro; (ii) epitope-specific monoclonal antibodies to trap individual PKS modules in
specific conformational or catalytic states; and (iii) advances in X-ray, SAXS, and cryoEM analysis of PKSs.
2) De-orphanize the nocardiosis-associated NOCAP synthase: We have de-orphanized the nonamodular
NOCAP synthase found in isolates of Nocardia associated with nocardiosis. Now, we propose to solve the
structure of the fully tailored natural product, and to elucidate its biological role in nocardiosis. This will require
us to: (i) characterize a putatively doubly glycosylated polyketide product; (ii) establish a phenotypic assay for
its bioactivity in a macrophage-like human cell line; and (ii) harness genome-wide CRISPR knockout and
shRNA knockdown screens to gain insight into its mode of action.
3) Decipher the role of GRINS in the evolution of assembly-line PKSs: We have discovered a new genetic
element, named GRINS (genetic repeats of intense nucleotide skews), that is widespread in assembly-line
PKS genes. We hypothesize that GRINS play a major role in diversifying assembly-line PKSs. To test this
hypothesis, we will: (i) identify candidate genes in Streptomyces that are involved in introducing nucleotide
skews or enabling gene conversion; (ii) identify a bacterial host in which gene conversion is enabled by GRINS
under laboratory conditions; and (iii) develop an experimental model for GRINS-based PKS engineering.
The significance of our proposal is two-fold. On one hand, it offers the opportunity to break new ground in our
understanding of the structure, mechanism, and evolution of assembly-line PKSs. On the other hand, it tests
the extent to which our understanding of these remarkable megasynthases can be harnessed to discover
novel bioactive polyketides from “orphan” assembly-line PKSs.
项目描述
组装线聚酮化合物合酶(PKS)是促催化近代生物合成的酶
通过独特定义的酰基载体蛋白和酮合酶的序列生长的聚酮链链
涉及替代链易位和伸长反应的域。尽管发现
> 3000个天然存在的装配线PKS,我们不了解它们如何将催化特异性与
进化灵活性。我们的实验室的动机是理解酶学和演变的目标
组装行PKS同时增强了我们设计已知PKS并解码“孤儿”的能力。
我们接下来五年的目标是:
1)通过组装行PKS了解矢量生物合成的化学逻辑:我们将研究:(i)
单个PKS模块的结构动力学; (ii)模块的不同考虑如何使其能够
基本反应; (iii)成功反应之间的过渡的程度
跨组装线。我们提出的机械投资将利用:(i)我们在功能上的能力
在体外重构PKS; (ii)表位特异性单克隆抗体可将单个PKS模块捕获
特定会议或催化状态; (iii)PKS的X射线,SAXS和冷冻分析的进步。
2)将甲型甲氧化作用相关的NOCAP合酶:我们已脱苯甲酸化
NOCAP合酶在与Nocardiosis相关的Nocardia分离株中发现。现在,我们建议解决
完全量身定制的天然产物的结构,并阐明其生物学在诺卡症中的作用。这将需要
我们要:(i)表征推定的双倍糖基化聚酮化合物; (ii)建立表型测定
它在巨噬细胞状的人类细胞系中的生物活性; (ii)宽松基因组CRISPR敲除和
shRNA敲低筛选以深入了解其作用方式。
3)破译笑容在组装线PKS演变中的作用:我们发现了一个新的通用
元素,名为Grins(强烈的核苷酸偏斜的遗传重复),在组装线上很普遍
PKS基因。我们假设笑容在多样化的组装线PKS中起着重要作用。测试这个
假设,我们将:(i)确定参与引入核苷酸的链霉菌中的候选基因
偏向或启用基因转换; (ii)确定一个细菌宿主,在该宿主中启用基因转换
在实验室条件下; (iii)为基于笑的PKS工程开发了一个实验模型。
我们的提议的意义是两个方面。一方面,它提供了机会在我们的
了解组装线PKS的结构,机制和演变。另一方面,它测试
我们对这些非凡的巨型统计的理解的程度可以利用
来自“孤儿”组装线PKS的新型生物活性聚酮化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHAITAN KHOSLA其他文献
CHAITAN KHOSLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHAITAN KHOSLA', 18)}}的其他基金
Mechanisms and Evolution of Assembly-Line Polyketide Synthases
装配线聚酮化合物合成酶的机制和演变
- 批准号:
10620652 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别:
Mechanisms and Evolution of Assembly-Line Polyketide Synthases
装配线聚酮化合物合成酶的机制和演变
- 批准号:
10205865 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别:
Preclinical Validation of Transglutaminase 2 as a Novel Target for Celiac Disease
转谷氨酰胺酶 2 作为乳糜泻新靶点的临床前验证
- 批准号:
9306054 - 财政年份:2014
- 资助金额:
$ 40.12万 - 项目类别:
Preclinical Validation of Transglutaminase 2 as a Novel Target for Celiac Disease
转谷氨酰胺酶 2 作为乳糜泻新靶点的临床前验证
- 批准号:
8767913 - 财政年份:2014
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
8362042 - 财政年份:2011
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
8169915 - 财政年份:2010
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
7954171 - 财政年份:2009
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
7721752 - 财政年份:2008
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
7597937 - 财政年份:2007
- 资助金额:
$ 40.12万 - 项目类别:
CHAITAN KHOSLA PRT-CRYSTAL STRUCTURES OF POLYKETIDE
CHAITAN KHOSLA PRT-聚酮化合物的晶体结构
- 批准号:
7370401 - 财政年份:2006
- 资助金额:
$ 40.12万 - 项目类别:
相似国自然基金
基于细胞药代动力学的氨基糖苷类抗生素耳肾线粒体损伤及PGC-1α代谢调控的机制研究
- 批准号:82304612
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境兽用抗生素暴露对儿童心血管危险因素聚集影响及SCAP-SREBP脂代谢通路基因甲基化调控机制研究
- 批准号:82373593
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
抗生素对不同生长阶段蓝藻光合电子传递和生理代谢的影响及分子机制研究
- 批准号:52300219
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗生素通过肠道菌群影响蜜蜂代谢稳态的分子机制研究
- 批准号:32370550
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
环境低剂量抗生素暴露对儿童肠道菌群和代谢组的影响
- 批准号:82311530106
- 批准年份:2023
- 资助金额:9 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
Harnessing Polyketide Assembly Lines for Medicinal Chemistry
利用聚酮化合物装配线进行药物化学
- 批准号:
10651828 - 财政年份:2022
- 资助金额:
$ 40.12万 - 项目类别:
Mechanisms and Evolution of Assembly-Line Polyketide Synthases
装配线聚酮化合物合成酶的机制和演变
- 批准号:
10620652 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别:
Expanding the Library of (Un)Natural Products through Megasynthase Docking Domain Engineering
通过大合酶对接域工程扩展(非)天然产物库
- 批准号:
10477963 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别:
Mechanisms and Evolution of Assembly-Line Polyketide Synthases
装配线聚酮化合物合成酶的机制和演变
- 批准号:
10205865 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别:
Creating natural product diversity via the fabrication of a hybrid fatty acid-nonribosomal peptide synthetase
通过制造杂合脂肪酸-非核糖体肽合成酶创造天然产物多样性
- 批准号:
10339399 - 财政年份:2021
- 资助金额:
$ 40.12万 - 项目类别: